Effect of a 14-day course of foscarnet on cytomegalovirus (CMV) blood markers in a randomized study of human immunodeficiency virus-infected patients with persistent CMV viremia. Agence National de Recherche du SIDA 023 Study Group.

MLA

Salmon-Céron, D., et al. “Effect of a 14-Day Course of Foscarnet on Cytomegalovirus (CMV) Blood Markers in a Randomized Study of Human Immunodeficiency Virus-Infected Patients with Persistent CMV Viremia. Agence National de Recherche Du SIDA 023 Study Group.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 28, no. 4, Apr. 1999, pp. 901–05. EBSCOhost, https://doi.org/10.1086/515223.

APA

Salmon-Céron, D., Fillet, A. M., Aboulker, J. P., Gérard, L., Houhou, N., Carrière, I., Ostinelli, J., Vildé, J. L., Brun-Vézinet, F., & Leport, C. (1999). Effect of a 14-day course of foscarnet on cytomegalovirus (CMV) blood markers in a randomized study of human immunodeficiency virus-infected patients with persistent CMV viremia. Agence National de Recherche du SIDA 023 Study Group. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 28(4), 901–905. https://doi.org/10.1086/515223

Chicago

Salmon-Céron, D, A M Fillet, J P Aboulker, L Gérard, N Houhou, I Carrière, J Ostinelli, J L Vildé, F Brun-Vézinet, and C Leport. 1999. “Effect of a 14-Day Course of Foscarnet on Cytomegalovirus (CMV) Blood Markers in a Randomized Study of Human Immunodeficiency Virus-Infected Patients with Persistent CMV Viremia. Agence National de Recherche Du SIDA 023 Study Group.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 28 (4): 901–5. doi:10.1086/515223.